Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter RCAS1 Antikörper

Der Kaninchen Monoklonal Anti-RCAS1-Antikörper wurde für IHC (f) validiert. Er ist geeignet, RCAS1 in Proben von Human zu detektieren.
Produktnummer ABIN7127131

Kurzübersicht für Rekombinanter RCAS1 Antikörper (ABIN7127131)

Target

Alle RCAS1 (EBAG9) Antikörper anzeigen
RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 57
  • 31
  • 13
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 41
  • 29
  • 2
Kaninchen

Klonalität

  • 43
  • 29
Monoklonal

Konjugat

  • 30
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser RCAS1 Antikörper ist unkonjugiert

Applikation

  • 33
  • 29
  • 20
  • 16
  • 14
  • 13
  • 13
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Spezifität

    EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human full-length EBAG9 protein

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: MCF-7, Jurkat or 293 cell lysates. Human skeletal muscle tissue.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    RCAS1 (EBAG9) (Estrogen Receptor Binding Site Associated, Antigen, 9 (EBAG9))

    Andere Bezeichnung

    EBAG9

    Hintergrund

    BAG9, cancer associated surface antigen, cancer associated surface antigen RCAS1, EB9, estrogen receptor binding fragment associated gene 9, PDAF, receptor binding cancer antigen expressed on SiSo cells,RCAS1 / Estrogen Receptor Binding Site Associated, Antigen 9
    Cellular localisation: Golgi apparatus.

    Molekulargewicht

    32kDa

    Gen-ID

    9166, 409368

    UniProt

    O00559
Sie sind hier:
Chat with us!